Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000475512 | SCV000563480 | likely benign | Neurofibromatosis, type 2 | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402369 | SCV002707416 | likely benign | Hereditary cancer-predisposing syndrome | 2021-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000475512 | SCV004817164 | likely benign | Neurofibromatosis, type 2 | 2023-02-24 | criteria provided, single submitter | clinical testing |